high-risk children
Showing 1 - 25 of >10,000
Heart Disease Congenital Trial (NCC Support Toolkit)
Not yet recruiting
- Heart Disease Congenital
- NCC Support Toolkit
- (no location specified)
Jul 5, 2023
Type 1 Diabetes Trial in Washington (SMA visits)
Recruiting
- Type 1 Diabetes
- SMA visits
-
Washington, District of ColumbiaChildren's National Hospital
Aug 8, 2022
Dental Plaque, Dental Caries Trial in Alexandria (Novamin containing toothpaste, Fluoride containing toothpaste)
Completed
- Dental Plaque
- Dental Caries
- Novamin containing toothpaste
- Fluoride containing toothpaste
-
Alexandria, EgyptAlexandria Faculty of Dentistry
Jul 29, 2023
SARS-CoV-2 Infection Trial in Baltimore (Anti-SARS-CoV-2 Human Convalescent Plasma)
Completed
- SARS-CoV-2 Infection
- Anti-SARS-CoV-2 Human Convalescent Plasma
-
Baltimore, MarylandJohns Hopkins Hospitals
Dec 14, 2021
Suicide, Attempted, Suicide Ideation, Suicide Trial (Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+),
Not yet recruiting
- Suicide, Attempted
- +3 more
- Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+)
- Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI)
- (no location specified)
Nov 21, 2023
RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (RSVpreF 120 µg, RSVpreF 60 µg, )
Not yet recruiting
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- RSVpreF 120 µg
- +2 more
- (no location specified)
Jun 2, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)
Completed
- Glioblastomas
- +4 more
- Enhanced Mindfulness Intervention
- Psychoeducation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 14, 2022
High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)
Active, not recruiting
- High-risk Neuroblastoma
- Dinutuximab Beta
- 13 cis retinoic acid
-
Beijing, Beijing, China
- +3 more
Dec 7, 2022
Cerebral Palsy Trial in Philadelphia (Prone and Upright Locomotor Training)
Recruiting
- Cerebral Palsy
- Prone and Upright Locomotor Training
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jan 4, 2023
Pediatric Asthma Trial in Little Rock (PEAKmAAP, PEAKmAAP-DS, NutriMap Usual Care)
Recruiting
- Pediatric Asthma
- PEAKmAAP
- +2 more
-
Little Rock, ArkansasArkansas Children's Hospital Research Institute
Feb 1, 2023
Development of Peanut, Sesame, and Tree Nut Allergy in Polish
Not yet recruiting
- Atopic Dermatitis
- +3 more
- Assessment of peanut, tree nuts and sesame allergy
-
Warsaw, Masovian, Poland
- +1 more
Dec 14, 2022
Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)
Recruiting
- Neuroblastoma
- +2 more
-
Columbus, OhioNationwide Children's Hospital
Dec 20, 2022
CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)
Recruiting
- CNS Tumor
- Solid Tumor
- Nivolumab and Entinostat
-
Randwick, New South Wales, Australia
- +13 more
Nov 8, 2022
Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)
Active, not recruiting
- Sickle Cell Disease
- CD34 selected T-cell depleted allogeneic SCT
-
Los Angeles, California
- +5 more
Sep 27, 2022
Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)
Not yet recruiting
- Leukemia
- 90-Yttrium-labelled anti-CD66 monoclonal antibody
- (no location specified)
Aug 16, 2022
Suicide Attempts, Suicidal Ideation, Suicide and Self-harm Trial in Columbus, Seattle (Safety Planning Intervention+ (SPI+),
Recruiting
- Suicide Attempts
- +3 more
- Safety Planning Intervention+ (SPI+)
- +2 more
-
Columbus, Ohio
- +1 more
Aug 11, 2022
Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,
Not yet recruiting
- Lymphocytes
- Tumor-Infiltrating
- Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
-
Saint Petersburg, Florida
- +1 more
Sep 15, 2023
Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))
Recruiting
- Solid Tumor
- Tumor-associated antigen-specific T cell (TAA-T)
-
Washington, District of ColumbiaChildren's National Hospital
Oct 24, 2022
Pediatric Anaplastic Large Cell Lymphoma Trial in Shanghai (P regimen, Course A1 + Vin, Course B1 +Vin)
Recruiting
- Pediatric Anaplastic Large Cell Lymphoma
- P regimen
- +7 more
-
Shanghai, ChinaShanghai Children's Medical Center
Jul 23, 2022
Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)
Terminated
- Neuroblastoma Recurrent
- Naxitamab and GM-CSF in combination with irinotecan and temozolomide
-
Hong Kong, Hong Kong
- +2 more
Nov 8, 2022